DeviceClearance

Product code QXX— Cardiovascular

CorVista® System

Classification name
Coronary Artery Disease Machine Learning-Based Notification Software
Device class
Class 2
Regulation
21 CFR 870.2380
Advisory panel
Cardiovascular
Total cleared
1
First cleared
Most recent

FDA classification definition

“Coronary Artery Disease machine learning-based notification software employs machine learning techniques to suggest the likelihood of coronary artery disease for further referral or diagnostic follow-up.”

— U.S. Food and Drug Administration, device classification record for product code QXX under 21 CFR 870.2380, via openFDA

Market context for product code QXX

FDA has cleared 1 device under product code QXX, all in 2023, filed by 1 applicant company. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Top applicants under product code QXX

Recent clearances under product code QXX

Data sourced from openFDA. This site is unofficial and independent of the FDA.